VistaGen Therapeutics (VTGN) AGM 2026 summary

Opening remarks and agenda

• Meeting held virtually to maximize stockholder participation and accessibility.

• Agenda included three business items: election of directors, advisory vote on executive compensation, and ratification of the independent auditor.

• Only questions related to agenda items were addressed during the meeting.

Board and executive committee updates

• Introduction of board members, management team, and representatives from the independent auditing firm.

• Attendance included key executives such as the CEO, CFO, and other senior officers.

Shareholder proposals

• Election of four directors for one-year terms was proposed and put to a vote.

• Advisory vote on executive compensation (Say on Pay) was proposed and seconded.

• Ratification of KPMG LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027, was proposed and seconded.